: FDA committee supports authorization of Moderna’s COVID-19 vaccine
An independent advisory committee on Thursday voted 20-0-1 that the benefits of Moderna Inc.’s COVID-19 vaccine candidate outweigh the risks, a recommendation that sets the stage for the likely second FDA authorization of a vaccine during the pandemic.
